Besides changes in the classical pro-inflammatory cytokines and nitric oxide pathways, analysis of the proposed AD biomarkers CHI3L1 and TREM2 may help us to understand the mechanisms involved in neuroinflammatory changes. This evidence concerns the gene TREM2 and Alzheimer disease.